We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why it is Worth Betting on Cigna Stock for Your Portfolio
Read MoreHide Full Article
Cigna Corporation (CI - Free Report) is well-placed for growth on the back of its strategic acquisitions, strong international business and a rising top line.
Estimates for the stock have been revised upward over the past 30 days, reflecting analysts' optimism on the stock. The stock has seen the Zacks Consensus Estimate for 2019 earnings move 0.2% north over the same time frame.
The company even boasts a favorable earnings surprise history, having exceeded the Zacks Consensus Estimate in three of the trailing four quarters, the average beat being 7.4%. This also highlights the company’s operating excellence.
The stock carries an impressive VGM Score of B. Here V stands for Value, G for Growth and M for Momentum with the score being a weighted combination of all three factors.
Its return on equity — a profitability measure — stands at 14.2%, better than its industry's average of 7.9%.
The company looks well-poised for 2019 with the buyout of Express Scripts, the pharmacy benefits manager. The merged company is now a one-stop shop for customers' healthcare needs, ranging from the sale of drugs to insurance cover. Consumers will also gain traction from this consolidation as this is expected to improve treatments and lower medical costs.
The combined entity will be able to rise in ranks in the health insurance industry, thereby strengthening its competitive edge. This transaction would lead to total cost synergies of $650 million and a double-digit accretion to earnings in 2019.
The company has also been putting in efforts to expand its international operations, which have been contributing to its top- and bottom-line growth for the past many years. The company has its global businesses in places like India, Turkey, Hong Kong, etc. with the largest operation being in South Korea where it has been active for more than three decades.
Cigna’s revenue stream has been pretty impressive as is evident from its 2010-2018 CAGR of 11%. This growth can be attributable to the company’s specific acquisitions, its operating performance and provision of quality products and services.
Following solid results, the company provided a strong guidance, which should instill investors’ confidence in the stock. For 2019, Cigna expects earnings per share in the range of $16.25-$16.65, up from the prior range of $16-$16.50. Total revenues are projected in the $132.5-$134.5 billion band (earlier estimate was $131.5-$133.5 billion).
The company’s long-term growth rate is pegged at 12.2%, higher than the industry's average of 11.5%, which remains a positive for the company.
The Zacks Consensus Estimate for current-year earnings per share is pegged at $16.57, suggesting a rise of 16.5% on 178.1% higher revenues of $133.83 billion from the year-ago reported figures.
For 2020, the Zacks Consensus Estimate for earnings per share stands at $18.58 on $141.56 billion revenues, implying a respective 12.2% and 5.8% from the prior-year reported numbers.
Shares of this Zacks Rank #2 (Buy) company have lost 9% in a year’s time against its industry’s growth of 2%.
WellCare Health offers managed care services to government-sponsored health care programs. The company pulled off average positive surprise of 13.52% in the preceding four quarters. It holds a Zacks Rank of 2.
HCA Healthcare provides health care services. In the last four quarters, the company delivered average beat of 15.74%. It is a Zacks #2 Ranked player.
Molina Healthcare is a multi-state healthcare organization. In the trailing four quarters, the company came up with average beat of 88.17%. It sports a Zacks Rank #1 (Strong Buy).
This Could Be the Fastest Way to Grow Wealth in 2019
Research indicates one sector is poised to deliver a crop of the best-performing stocks you'll find anywhere in the market. Breaking news in this space frequently creates quick double- and triple-digit profit opportunities.
These companies are changing the world – and owning their stocks could transform your portfolio in 2019 and beyond. Recent trades from this sector have generated +98%, +119% and +164% gains in as little as 1 month.
Image: Bigstock
Why it is Worth Betting on Cigna Stock for Your Portfolio
Cigna Corporation (CI - Free Report) is well-placed for growth on the back of its strategic acquisitions, strong international business and a rising top line.
Estimates for the stock have been revised upward over the past 30 days, reflecting analysts' optimism on the stock. The stock has seen the Zacks Consensus Estimate for 2019 earnings move 0.2% north over the same time frame.
The company even boasts a favorable earnings surprise history, having exceeded the Zacks Consensus Estimate in three of the trailing four quarters, the average beat being 7.4%. This also highlights the company’s operating excellence.
The stock carries an impressive VGM Score of B. Here V stands for Value, G for Growth and M for Momentum with the score being a weighted combination of all three factors.
Its return on equity — a profitability measure — stands at 14.2%, better than its industry's average of 7.9%.
The company looks well-poised for 2019 with the buyout of Express Scripts, the pharmacy benefits manager. The merged company is now a one-stop shop for customers' healthcare needs, ranging from the sale of drugs to insurance cover. Consumers will also gain traction from this consolidation as this is expected to improve treatments and lower medical costs.
The combined entity will be able to rise in ranks in the health insurance industry, thereby strengthening its competitive edge. This transaction would lead to total cost synergies of $650 million and a double-digit accretion to earnings in 2019.
The company has also been putting in efforts to expand its international operations, which have been contributing to its top- and bottom-line growth for the past many years. The company has its global businesses in places like India, Turkey, Hong Kong, etc. with the largest operation being in South Korea where it has been active for more than three decades.
Cigna’s revenue stream has been pretty impressive as is evident from its 2010-2018 CAGR of 11%. This growth can be attributable to the company’s specific acquisitions, its operating performance and provision of quality products and services.
Following solid results, the company provided a strong guidance, which should instill investors’ confidence in the stock. For 2019, Cigna expects earnings per share in the range of $16.25-$16.65, up from the prior range of $16-$16.50. Total revenues are projected in the $132.5-$134.5 billion band (earlier estimate was $131.5-$133.5 billion).
The company’s long-term growth rate is pegged at 12.2%, higher than the industry's average of 11.5%, which remains a positive for the company.
The Zacks Consensus Estimate for current-year earnings per share is pegged at $16.57, suggesting a rise of 16.5% on 178.1% higher revenues of $133.83 billion from the year-ago reported figures.
For 2020, the Zacks Consensus Estimate for earnings per share stands at $18.58 on $141.56 billion revenues, implying a respective 12.2% and 5.8% from the prior-year reported numbers.
Shares of this Zacks Rank #2 (Buy) company have lost 9% in a year’s time against its industry’s growth of 2%.
Other Key Picks
Investors interested in the medical sector can also take a look at some other top-ranked stocks like WellCare Health Plans, Inc. , HCA Healthcare, Inc. (HCA - Free Report) and Molina Healthcare, Inc (MOH - Free Report) . You can see the complete list of today’s Zacks #1 Rank stocks here.
WellCare Health offers managed care services to government-sponsored health care programs. The company pulled off average positive surprise of 13.52% in the preceding four quarters. It holds a Zacks Rank of 2.
HCA Healthcare provides health care services. In the last four quarters, the company delivered average beat of 15.74%. It is a Zacks #2 Ranked player.
Molina Healthcare is a multi-state healthcare organization. In the trailing four quarters, the company came up with average beat of 88.17%. It sports a Zacks Rank #1 (Strong Buy).
This Could Be the Fastest Way to Grow Wealth in 2019
Research indicates one sector is poised to deliver a crop of the best-performing stocks you'll find anywhere in the market. Breaking news in this space frequently creates quick double- and triple-digit profit opportunities.
These companies are changing the world – and owning their stocks could transform your portfolio in 2019 and beyond. Recent trades from this sector have generated +98%, +119% and +164% gains in as little as 1 month.
Click here to see these breakthrough stocks now >>